Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Granulomatosis with Polyangiitis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Granulomatosis with Polyangiitis (GPA) in Eyelid
Journal:
Medicine
Treatment Used:
Radiotherapy
Number of Patients:
0
Published —
February 06, 2021
This case report describes a 29-year-old man diagnosed with granulomatosis with polyangiitis (chronic blood vessel inflammation) occurring in the eyelid treated with radiotherapy.
Condition:
Exacerbation of a Severe Eosinophilic Asthma Associated with Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Journal:
BMC pulmonary medicine
Treatment Used:
Benralizumab
Number of Patients:
1
Published —
January 22, 2021
This article reviewed the effects of benralizumab in exacerbation (worsening) of severe eosinophilic asthma (type of severe asthma marked by high levels of white blood cells) associated with eosinophilic granulomatosis with polyangiitis (rare autoimmune condition that causes inflammation of small and medium-sized blood vessels in persons with a history of airway allergic hypersensitivity; EGPA).
Condition:
Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Systemic Vasculitis (AAV)
Journal:
Arthritis research & therapy
Treatment Used:
Plasma Exchange (PE)
Number of Patients:
964
Published —
January 15, 2021
This study assessed the effectiveness of plasma exchange (removal, treatment, and return or exchange of blood plasma; PE) for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (inflammation of small vessels; AAV).
Condition:
Eosinophilic Granulomatosis with Polyangiitis
Journal:
Autoimmunity reviews
Treatment Used:
Rituximab
Number of Patients:
171
Published —
December 19, 2020
In this study, researchers evaluated the outcomes of using rituximab for the treatment of eosinophilic granulomatosis with polyangiitis.
Condition:
Granulomatosis with Polyangiitis
Journal:
BMJ case reports
Treatment Used:
Avacopan
Number of Patients:
1
Published —
October 30, 2020
This study reports a case of a patient with granulomatosis with polyangiitis (GPA) who was treated with avacopan, a novel C5a receptor inhibitor, after conventional therapies were not working.
Condition:
Anti-Neutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Journal:
The Cochrane database of systematic reviews
Treatment Used:
Anti-Cytokine Targeted Therapy
Number of Patients:
440
Published —
September 29, 2020
This study tested the safety and efficacy of using anti-cytokine targeted therapy to treat patients with ANCA-associated vasculitis.
Condition:
False Positive COVID-19 Antibody Test in Patient with Granulomatosis With Polyangiitis (GPA)
Journal:
Frontiers in medicine
Treatment Used:
Methylprednisolone Pulses and Cyclophosphamide
Number of Patients:
1
Published —
August 01, 2020
This case report describes an 82-year-old female with granulomatosis with polyangitis (GPA) who had a false positive COVID-19 antibody test and was treated with methylprednisolone pulses and cyclophosphamide.
Condition:
Microscopic Polyangiitis (MPA) and Granulomatosis with Polyangiitis (GPA)
Journal:
Yonsei medical journal
Treatment Used:
Rituximab Biosimilar
Number of Patients:
139
Published —
August 01, 2020
This study investigated the effects of rituximab on poor outcomes for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).
Condition:
Peripheral Neuropathy in Eosinophilic Granulomatosis with Polyangiitis
Journal:
Journal of immunology research
Treatment Used:
Glucocorticoids with Immunosuppressants
Number of Patients:
0
Published —
July 28, 2020
The study researched the prevalence of peripheral neuropathy in eosinophilic granulomatosis with polyangiitis.
Condition:
Granulomatosis with Polyangiitis (GPA)
Journal:
PloS one
Treatment Used:
Mycophenolic Acid and 6-Mercaptopurine
Number of Patients:
85
Published —
July 10, 2020
This study investigated whether mycophenolate-mofetil (MMF) or azathioprine (AZA) alters the circulating B-cell distribution, proliferation, and cytokine production in patients with granulomatosis with polyangiitis (small blood vessel disease; GPA).
Condition:
ANCA-Associated Vasculitis
Journal:
Annals of the rheumatic diseases
Treatment Used:
Rituximab
Number of Patients:
188
Published —
June 26, 2020
In this study, researchers evaluated the outcomes of using rituximab for the treatment of relapsing ANCA-associated vasculitis.
Condition:
Antibody-associated Vasculitis
Journal:
Annals of internal medicine
Treatment Used:
Rituximab
Number of Patients:
97
Published —
June 02, 2020
In this study, researchers evaluated the outcomes of using rituximab for the treatment of antibody-associated vasculitis.
Showing 1-12 of 41
Next